|
⚲
|
| Keyboard |
| NQ Pof V GP Ltd | |
|---|---|
| Firm | NovaQuest Capital Management LLC |
| Address | c/o NovaQuest Capital Management, LLC 4208 Six Forks Road, Suite 920 Raleigh, NC 27609 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| NovaQuest Capital Management LLC | |||||
| NovaQuest Pharma Opportunities Fund V Delaware LP | 021-289381 | Executive Officer | 892.8 M of 1,500.0 M |
376.7 M | |
| NovaQuest Pharma Opportunities Fund V LP | 021-289380 | Executive Officer | 892.8 M of 1,500.0 M |
603.4 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Idera Pharmaceuticals Inc ACGN
Warrant · derivative
|
2023-01-17 | Conversion | 830,294 | ||
|
Idera Pharmaceuticals Inc ACGN
Warrant · derivative
|
2023-01-17 | Conversion | 14,115 | ||
|
Idera Pharmaceuticals Inc IDRA
Series X Preferred Stock
|
2022-09-28 | Other | 5 | ||
|
Idera Pharmaceuticals Inc IDRA
Series Z Preferred Stock · derivative
|
2022-09-28 | Other | 14,115 | ||
|
Idera Pharmaceuticals Inc IDRA
Warrant · derivative
|
2022-09-28 | Other | 14,115 | ||
|
Idera Pharmaceuticals Inc IDRA
Warrant · derivative
|
2022-09-28 | Other | 1,343,547 |